title: T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models.
abstract: The 17D line of yellow fever virus vaccines is among the most effective vaccines ever created. The humoral and cellular immunity elicited by 17D has been well characterized in humans. Neutralizing antibodies have long been known to provide protection against challenge with a wild-type virus. However, a well characterized T cell immune response that is robust, long-lived and polyfunctional is also elicited by 17D. It remains unclear whether this arm of immunity is protective following challenge with a wild-type virus. Here we introduce the 17D line of yellow fever virus vaccines, describe the current state of knowledge regarding the immunity directed towards the vaccines in humans and conclude with a discussion of animal models that are useful for evaluating T cell-mediated immune protection to yellow fever virus.
authors.affiliation: Center for Vaccine Research, Departments of Microbiology and Molecular Genetics, and Immunology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA. alan.watson@pitt.edu.
authors.forename: Alan M
authors.initials: AM
authors.lastname: Watson
authors.affiliation: Center for Vaccine Research, Departments of Microbiology and Molecular Genetics, and Immunology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA. klimstra@pitt.edu.
authors.forename: William B
authors.initials: WB
authors.lastname: Klimstra
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology*; D022341:Yellow Fever Vaccine / Q000276:immunology*; D015005:Yellow fever virus / Q000276:immunology*
chemical_list: D022341:Yellow Fever Vaccine
keywords: 17D; 17D-204; 17DD; T cell; West Nile; YFV; Zika; animal models; chimerivax; dengue; flavivirus; live attenuated vaccine; vaccine; vaccine development; yellow fever virus